 Steve Groshong
Concepts (306)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Idiopathic Pulmonary Fibrosis | 14 | 2021 | 511 | 1.120 |
Why?
| | Lung Diseases, Interstitial | 12 | 2017 | 520 | 0.680 |
Why?
| | Lung | 23 | 2020 | 3683 | 0.630 |
Why?
| | Mucin-5B | 6 | 2018 | 185 | 0.460 |
Why?
| | Pulmonary Fibrosis | 6 | 2020 | 331 | 0.450 |
Why?
| | Tomography, X-Ray Computed | 10 | 2021 | 2404 | 0.430 |
Why?
| | Biopsy | 9 | 2019 | 1056 | 0.430 |
Why?
| | Fibroblasts | 6 | 2020 | 838 | 0.350 |
Why?
| | Bleomycin | 3 | 2020 | 232 | 0.320 |
Why?
| | Lung Diseases | 2 | 2018 | 710 | 0.320 |
Why?
| | Interdisciplinary Communication | 1 | 2009 | 185 | 0.310 |
Why?
| | Machine Learning | 3 | 2019 | 320 | 0.280 |
Why?
| | Bronchoscopy | 4 | 2018 | 245 | 0.260 |
Why?
| | Emergency Medical Technicians | 1 | 2006 | 42 | 0.260 |
Why?
| | Infusions, Intravenous | 1 | 2006 | 374 | 0.250 |
Why?
| | Alveolitis, Extrinsic Allergic | 2 | 2020 | 92 | 0.240 |
Why?
| | Acute Lung Injury | 2 | 2022 | 302 | 0.230 |
Why?
| | Peritoneal Neoplasms | 1 | 2004 | 54 | 0.230 |
Why?
| | Diagnosis, Differential | 8 | 2020 | 1359 | 0.220 |
Why?
| | Teratoma | 1 | 2004 | 92 | 0.220 |
Why?
| | Middle Aged | 31 | 2021 | 27078 | 0.200 |
Why?
| | Research Report | 1 | 2022 | 76 | 0.190 |
Why?
| | Cough | 2 | 2015 | 107 | 0.190 |
Why?
| | Apoptosis | 4 | 2018 | 2377 | 0.190 |
Why?
| | Glioma | 1 | 2004 | 296 | 0.180 |
Why?
| | Bronchial Diseases | 2 | 2012 | 38 | 0.180 |
Why?
| | Biomarkers, Tumor | 4 | 2014 | 1045 | 0.180 |
Why?
| | Inflammation | 5 | 2022 | 2502 | 0.180 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 1 | 2020 | 23 | 0.180 |
Why?
| | Lung Neoplasms | 4 | 2018 | 2206 | 0.180 |
Why?
| | Myofibroblasts | 2 | 2018 | 116 | 0.170 |
Why?
| | Phenotype | 5 | 2015 | 2859 | 0.170 |
Why?
| | Ovarian Neoplasms | 1 | 2004 | 407 | 0.170 |
Why?
| | Transforming Growth Factor beta | 2 | 2020 | 447 | 0.170 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 1 | 2018 | 7 | 0.160 |
Why?
| | Common Variable Immunodeficiency | 1 | 2018 | 29 | 0.160 |
Why?
| | Dihematoporphyrin Ether | 1 | 2018 | 3 | 0.160 |
Why?
| | Sarcoidosis, Pulmonary | 2 | 2009 | 58 | 0.160 |
Why?
| | Aged | 20 | 2021 | 19292 | 0.150 |
Why?
| | Photochemotherapy | 1 | 2018 | 29 | 0.150 |
Why?
| | Photosensitizing Agents | 1 | 2018 | 26 | 0.150 |
Why?
| | Sequence Analysis, RNA | 2 | 2017 | 390 | 0.150 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 273 | 0.150 |
Why?
| | Complement C3 | 1 | 2018 | 191 | 0.140 |
Why?
| | Humans | 44 | 2021 | 115859 | 0.140 |
Why?
| | Gene Expression Regulation | 3 | 2016 | 2365 | 0.140 |
Why?
| | Case-Control Studies | 8 | 2018 | 3054 | 0.140 |
Why?
| | Adenocarcinoma | 2 | 2018 | 797 | 0.130 |
Why?
| | HLA-DQ beta-Chains | 1 | 2016 | 61 | 0.130 |
Why?
| | Genomics | 1 | 2021 | 653 | 0.130 |
Why?
| | fas Receptor | 2 | 2018 | 93 | 0.130 |
Why?
| | HLA-DRB1 Chains | 1 | 2016 | 99 | 0.130 |
Why?
| | Female | 29 | 2021 | 60070 | 0.130 |
Why?
| | Genetic Loci | 2 | 2016 | 280 | 0.130 |
Why?
| | Genotype | 2 | 2018 | 1830 | 0.130 |
Why?
| | Idiopathic Interstitial Pneumonias | 1 | 2015 | 48 | 0.130 |
Why?
| | Male | 28 | 2021 | 56103 | 0.130 |
Why?
| | Epithelial Cells | 4 | 2020 | 961 | 0.120 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2014 | 57 | 0.120 |
Why?
| | Genome-Wide Association Study | 3 | 2016 | 1277 | 0.120 |
Why?
| | Receptors, Bombesin | 1 | 2014 | 4 | 0.120 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2014 | 964 | 0.110 |
Why?
| | Matrix Metalloproteinase 7 | 1 | 2013 | 24 | 0.110 |
Why?
| | Carcinoma, Small Cell | 1 | 2014 | 159 | 0.110 |
Why?
| | Dyspnea | 1 | 2015 | 224 | 0.110 |
Why?
| | Collagen | 2 | 2012 | 415 | 0.110 |
Why?
| | Genetic Variation | 1 | 2018 | 893 | 0.110 |
Why?
| | Mucin 5AC | 1 | 2013 | 48 | 0.110 |
Why?
| | Disease Models, Animal | 5 | 2018 | 3587 | 0.110 |
Why?
| | Adult | 16 | 2021 | 30814 | 0.110 |
Why?
| | E2F1 Transcription Factor | 1 | 2012 | 57 | 0.100 |
Why?
| | Lymphatic Vessels | 1 | 2012 | 54 | 0.100 |
Why?
| | Immunohistochemistry | 6 | 2018 | 1644 | 0.100 |
Why?
| | Bronchi | 1 | 2013 | 250 | 0.100 |
Why?
| | Cilia | 1 | 2013 | 163 | 0.100 |
Why?
| | Trachea | 1 | 2013 | 233 | 0.100 |
Why?
| | Algorithms | 1 | 2019 | 1494 | 0.100 |
Why?
| | Up-Regulation | 2 | 2013 | 824 | 0.100 |
Why?
| | Arthritis, Rheumatoid | 2 | 2012 | 1003 | 0.100 |
Why?
| | Lipopolysaccharides | 2 | 2012 | 832 | 0.100 |
Why?
| | Chromosomes, Human, Pair 11 | 1 | 2011 | 66 | 0.090 |
Why?
| | Mice | 10 | 2020 | 15085 | 0.090 |
Why?
| | Sensitivity and Specificity | 3 | 2021 | 1725 | 0.090 |
Why?
| | Genetic Markers | 3 | 2021 | 336 | 0.090 |
Why?
| | beta Carotene | 1 | 2010 | 18 | 0.090 |
Why?
| | Severity of Illness Index | 3 | 2015 | 2590 | 0.090 |
Why?
| | Animals | 13 | 2022 | 32158 | 0.090 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2015 | 2004 | 0.090 |
Why?
| | Virus Replication | 2 | 2009 | 396 | 0.090 |
Why?
| | Peptides, Cyclic | 1 | 2012 | 262 | 0.090 |
Why?
| | Asthma | 2 | 2015 | 2150 | 0.090 |
Why?
| | Pulmonary Medicine | 1 | 2011 | 88 | 0.090 |
Why?
| | Hemorrhage | 1 | 2014 | 617 | 0.090 |
Why?
| | Serum Amyloid A Protein | 1 | 2009 | 29 | 0.090 |
Why?
| | Coronavirus, Rat | 1 | 2009 | 1 | 0.090 |
Why?
| | Pulmonary Alveoli | 2 | 2009 | 376 | 0.090 |
Why?
| | Proteins | 1 | 2015 | 920 | 0.090 |
Why?
| | Salivary Glands, Minor | 1 | 2009 | 8 | 0.080 |
Why?
| | Prospective Studies | 6 | 2021 | 6276 | 0.080 |
Why?
| | CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2009 | 20 | 0.080 |
Why?
| | Immunity, Innate | 2 | 2012 | 735 | 0.080 |
Why?
| | Societies, Medical | 2 | 2011 | 685 | 0.080 |
Why?
| | Gene Expression Profiling | 5 | 2016 | 1550 | 0.080 |
Why?
| | Gammaherpesvirinae | 1 | 2009 | 38 | 0.080 |
Why?
| | Lymphoproliferative Disorders | 1 | 2009 | 46 | 0.080 |
Why?
| | Toll-Like Receptor 2 | 1 | 2009 | 114 | 0.080 |
Why?
| | Sjogren's Syndrome | 1 | 2009 | 42 | 0.080 |
Why?
| | Signal Transduction | 2 | 2020 | 4527 | 0.080 |
Why?
| | Actinomycosis | 1 | 2008 | 4 | 0.080 |
Why?
| | Mycobacterium avium-intracellulare Infection | 1 | 2009 | 63 | 0.080 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2009 | 112 | 0.080 |
Why?
| | Scleroderma, Limited | 1 | 2008 | 5 | 0.080 |
Why?
| | Hypertension, Pulmonary | 2 | 2012 | 1752 | 0.080 |
Why?
| | Herpesviridae Infections | 1 | 2009 | 138 | 0.080 |
Why?
| | Reproducibility of Results | 3 | 2021 | 2807 | 0.070 |
Why?
| | Colitis, Ischemic | 1 | 2007 | 6 | 0.070 |
Why?
| | Granulomatosis with Polyangiitis | 1 | 2007 | 42 | 0.070 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2007 | 25 | 0.070 |
Why?
| | Escherichia coli O157 | 1 | 2007 | 30 | 0.070 |
Why?
| | Foreign Bodies | 1 | 2008 | 99 | 0.070 |
Why?
| | Pneumonia | 2 | 2009 | 576 | 0.070 |
Why?
| | Neoplasm Proteins | 1 | 2010 | 388 | 0.070 |
Why?
| | Autoantibodies | 2 | 2012 | 1362 | 0.070 |
Why?
| | Diagnostic Imaging | 1 | 2009 | 296 | 0.070 |
Why?
| | Escherichia coli Infections | 1 | 2007 | 102 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2020 | 3914 | 0.070 |
Why?
| | Dietary Supplements | 1 | 2010 | 460 | 0.070 |
Why?
| | Pulmonary Artery | 1 | 2012 | 1032 | 0.070 |
Why?
| | Aged, 80 and over | 5 | 2021 | 6434 | 0.070 |
Why?
| | Missouri | 1 | 2006 | 63 | 0.070 |
Why?
| | Mice, Knockout | 3 | 2018 | 2608 | 0.070 |
Why?
| | Interferon-gamma | 1 | 2009 | 733 | 0.070 |
Why?
| | Ambulances | 1 | 2006 | 50 | 0.070 |
Why?
| | Promoter Regions, Genetic | 3 | 2018 | 1130 | 0.060 |
Why?
| | Gene Expression | 3 | 2017 | 1442 | 0.060 |
Why?
| | Retinoblastoma Protein | 1 | 2004 | 52 | 0.060 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2004 | 58 | 0.060 |
Why?
| | alpha-Fetoproteins | 1 | 2004 | 32 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2009 | 1137 | 0.060 |
Why?
| | Coronavirus Infections | 1 | 2009 | 336 | 0.060 |
Why?
| | B-Lymphocytes | 1 | 2009 | 771 | 0.060 |
Why?
| | Biopsy, Needle | 2 | 2018 | 183 | 0.060 |
Why?
| | Linkage Disequilibrium | 2 | 2016 | 268 | 0.050 |
Why?
| | Hysterectomy | 1 | 2004 | 118 | 0.050 |
Why?
| | Smoking | 1 | 2010 | 1465 | 0.050 |
Why?
| | Gene Frequency | 2 | 2015 | 506 | 0.050 |
Why?
| | Cohort Studies | 4 | 2017 | 4960 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 1813 | 0.050 |
Why?
| | Disease Progression | 3 | 2020 | 2423 | 0.050 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2004 | 213 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 3 | 2016 | 2201 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2013 | 754 | 0.050 |
Why?
| | Respiratory Function Tests | 2 | 2012 | 539 | 0.040 |
Why?
| | Interleukin-10 | 2 | 2014 | 304 | 0.040 |
Why?
| | Retrospective Studies | 6 | 2014 | 12615 | 0.040 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2004 | 577 | 0.040 |
Why?
| | Kaplan-Meier Estimate | 2 | 2014 | 816 | 0.040 |
Why?
| | Macrophages, Alveolar | 2 | 2014 | 357 | 0.040 |
Why?
| | Emergency Medical Services | 1 | 2006 | 591 | 0.040 |
Why?
| | Drug Resistance, Microbial | 1 | 2018 | 66 | 0.040 |
Why?
| | Chronic Disease | 2 | 2018 | 1598 | 0.040 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 67 | 0.040 |
Why?
| | A549 Cells | 1 | 2018 | 52 | 0.040 |
Why?
| | Rats | 3 | 2011 | 5035 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 4779 | 0.040 |
Why?
| | Occupational Exposure | 1 | 2020 | 262 | 0.040 |
Why?
| | Reference Values | 1 | 2018 | 745 | 0.040 |
Why?
| | Dogs | 1 | 2018 | 344 | 0.040 |
Why?
| | Pneumonectomy | 1 | 2018 | 126 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 545 | 0.030 |
Why?
| | Chromosomes, Human, Pair 6 | 1 | 2016 | 46 | 0.030 |
Why?
| | ROC Curve | 1 | 2017 | 451 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2007 | 1872 | 0.030 |
Why?
| | Down-Regulation | 1 | 2018 | 605 | 0.030 |
Why?
| | Flow Cytometry | 2 | 2009 | 1060 | 0.030 |
Why?
| | ADAMTS9 Protein | 1 | 2015 | 6 | 0.030 |
Why?
| | Serpin E2 | 1 | 2015 | 6 | 0.030 |
Why?
| | Procollagen N-Endopeptidase | 1 | 2015 | 8 | 0.030 |
Why?
| | ADAMTS4 Protein | 1 | 2015 | 16 | 0.030 |
Why?
| | Phosphorylation | 1 | 2020 | 1562 | 0.030 |
Why?
| | Serpins | 1 | 2015 | 27 | 0.030 |
Why?
| | E-Selectin | 1 | 2015 | 53 | 0.030 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2015 | 32 | 0.030 |
Why?
| | Neoplasms | 1 | 2009 | 2114 | 0.030 |
Why?
| | NF-kappa B | 2 | 2009 | 639 | 0.030 |
Why?
| | ADAM Proteins | 1 | 2015 | 60 | 0.030 |
Why?
| | Auscultation | 1 | 2015 | 4 | 0.030 |
Why?
| | Herpesviridae | 1 | 2015 | 21 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2015 | 89 | 0.030 |
Why?
| | Neutrophils | 2 | 2011 | 1171 | 0.030 |
Why?
| | Hemosiderin | 1 | 2014 | 2 | 0.030 |
Why?
| | Bleeding Time | 1 | 2014 | 6 | 0.030 |
Why?
| | Cell Line | 2 | 2011 | 2657 | 0.030 |
Why?
| | Asymptomatic Diseases | 1 | 2015 | 77 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2013 | 2196 | 0.030 |
Why?
| | Tetraspanin 24 | 1 | 2013 | 5 | 0.030 |
Why?
| | Integrin alpha6 | 1 | 2013 | 8 | 0.030 |
Why?
| | Young Adult | 3 | 2017 | 10508 | 0.030 |
Why?
| | Radiography, Thoracic | 1 | 2015 | 165 | 0.030 |
Why?
| | Fibrin | 1 | 2014 | 65 | 0.030 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 249 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2014 | 399 | 0.030 |
Why?
| | Thromboplastin | 1 | 2013 | 71 | 0.030 |
Why?
| | Clone Cells | 1 | 2013 | 247 | 0.030 |
Why?
| | Keratins | 1 | 2013 | 176 | 0.030 |
Why?
| | Chromosomes, Human | 1 | 2013 | 41 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor D | 1 | 2012 | 12 | 0.030 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2015 | 389 | 0.030 |
Why?
| | DNA, Viral | 1 | 2015 | 351 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor C | 1 | 2012 | 16 | 0.030 |
Why?
| | Lymphangiogenesis | 1 | 2012 | 24 | 0.030 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2013 | 129 | 0.030 |
Why?
| | Logistic Models | 1 | 2017 | 1863 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 77 | 0.030 |
Why?
| | Cysts | 1 | 2013 | 94 | 0.030 |
Why?
| | Blood Coagulation Factors | 1 | 2012 | 44 | 0.030 |
Why?
| | Alveolar Epithelial Cells | 1 | 2013 | 100 | 0.030 |
Why?
| | Regeneration | 1 | 2013 | 162 | 0.030 |
Why?
| | Airway Remodeling | 1 | 2012 | 60 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2015 | 633 | 0.020 |
Why?
| | Connective Tissue Diseases | 1 | 2012 | 71 | 0.020 |
Why?
| | Epoprostenol | 1 | 2012 | 132 | 0.020 |
Why?
| | Pulmonary Eosinophilia | 1 | 2011 | 27 | 0.020 |
Why?
| | Fas Ligand Protein | 1 | 2011 | 58 | 0.020 |
Why?
| | Sex Distribution | 1 | 2012 | 337 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2013 | 402 | 0.020 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 133 | 0.020 |
Why?
| | Respiratory Mucosa | 1 | 2013 | 258 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2014 | 1088 | 0.020 |
Why?
| | Cytochromes | 1 | 2010 | 9 | 0.020 |
Why?
| | Cocarcinogenesis | 1 | 2010 | 14 | 0.020 |
Why?
| | Spleen | 1 | 2012 | 492 | 0.020 |
Why?
| | Neovascularization, Pathologic | 1 | 2012 | 283 | 0.020 |
Why?
| | alpha-Tocopherol | 1 | 2010 | 24 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2011 | 314 | 0.020 |
Why?
| | Cyclin D1 | 1 | 2010 | 61 | 0.020 |
Why?
| | Endotoxins | 1 | 2011 | 208 | 0.020 |
Why?
| | Receptors, Retinoic Acid | 1 | 2010 | 50 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 737 | 0.020 |
Why?
| | Homeostasis | 1 | 2013 | 577 | 0.020 |
Why?
| | Radiography | 1 | 2012 | 826 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2012 | 504 | 0.020 |
Why?
| | Ki-67 Antigen | 1 | 2010 | 104 | 0.020 |
Why?
| | Purpura | 1 | 2009 | 12 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2009 | 34 | 0.020 |
Why?
| | Bacterial Infections | 1 | 2011 | 222 | 0.020 |
Why?
| | Granuloma | 1 | 2009 | 85 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2009 | 73 | 0.020 |
Why?
| | Multicenter Studies as Topic | 1 | 2010 | 249 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1227 | 0.020 |
Why?
| | Rats, Inbred F344 | 1 | 2009 | 245 | 0.020 |
Why?
| | Adolescent | 3 | 2017 | 17935 | 0.020 |
Why?
| | Binding Sites | 1 | 2012 | 1182 | 0.020 |
Why?
| | Elastin | 1 | 2009 | 78 | 0.020 |
Why?
| | Thrombosis | 1 | 2012 | 302 | 0.020 |
Why?
| | Pulmonary Surfactants | 1 | 2009 | 101 | 0.020 |
Why?
| | Gastroesophageal Reflux | 1 | 2011 | 235 | 0.020 |
Why?
| | Antihypertensive Agents | 1 | 2012 | 432 | 0.020 |
Why?
| | Myoblasts | 1 | 2009 | 77 | 0.020 |
Why?
| | DNA Topoisomerases, Type I | 1 | 2008 | 17 | 0.020 |
Why?
| | Testicular Neoplasms | 1 | 2009 | 95 | 0.020 |
Why?
| | Leukocytes | 1 | 2009 | 284 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2008 | 286 | 0.020 |
Why?
| | Transcriptome | 1 | 2013 | 742 | 0.020 |
Why?
| | Precision Medicine | 1 | 2011 | 356 | 0.020 |
Why?
| | Hepatitis C, Chronic | 1 | 2009 | 152 | 0.020 |
Why?
| | Phagocytosis | 1 | 2009 | 355 | 0.020 |
Why?
| | Lymphocytes | 1 | 2009 | 342 | 0.020 |
Why?
| | RNA | 1 | 2013 | 820 | 0.020 |
Why?
| | Pulmonary Circulation | 1 | 2009 | 407 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 796 | 0.020 |
Why?
| | Survival Analysis | 1 | 2010 | 1218 | 0.020 |
Why?
| | Anastomosis, Surgical | 1 | 2007 | 140 | 0.020 |
Why?
| | Transfection | 1 | 2009 | 868 | 0.020 |
Why?
| | Risk Factors | 1 | 2020 | 8715 | 0.020 |
Why?
| | Photomicrography | 1 | 2006 | 7 | 0.020 |
Why?
| | Colectomy | 1 | 2007 | 87 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2009 | 1169 | 0.020 |
Why?
| | Rare Diseases | 1 | 2007 | 90 | 0.020 |
Why?
| | Respiratory Insufficiency | 1 | 2010 | 292 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2013 | 1709 | 0.020 |
Why?
| | Lung Transplantation | 1 | 2008 | 246 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2009 | 1001 | 0.020 |
Why?
| | Abdominal Pain | 1 | 2007 | 136 | 0.020 |
Why?
| | MicroRNAs | 1 | 2012 | 610 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2010 | 1664 | 0.020 |
Why?
| | Acute Disease | 1 | 2008 | 917 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2009 | 677 | 0.020 |
Why?
| | Base Sequence | 1 | 2009 | 2121 | 0.020 |
Why?
| | Colonoscopy | 1 | 2007 | 204 | 0.020 |
Why?
| | Weight Loss | 1 | 2009 | 633 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2010 | 1217 | 0.020 |
Why?
| | Biomarkers | 1 | 2015 | 3474 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2011 | 2416 | 0.020 |
Why?
| | Liver | 1 | 2012 | 1693 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2006 | 1044 | 0.010 |
Why?
| | Uterine Cervical Dysplasia | 1 | 2004 | 39 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2008 | 595 | 0.010 |
Why?
| | Intestinal Mucosa | 1 | 2007 | 528 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2006 | 690 | 0.010 |
Why?
| | Cytokines | 1 | 2009 | 1858 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2009 | 2581 | 0.010 |
Why?
| | Mutation | 1 | 2011 | 3371 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2007 | 4443 | 0.010 |
Why?
| | United States | 1 | 2011 | 12319 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2007 | 9163 | 0.010 |
Why?
|
|
Groshong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|